TNNI3 antibody
Quick Overview for TNNI3 antibody (ABIN6658031)
Target
See all TNNI3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Supplier Product No.
- 100-401-x31
-
Supplier
- Rockland
-
Purpose
- Troponin I (cardiac) Antibody
-
Purification
- Anti-Troponin (cardiac) Antibody is a prepared sterile filter neat serum.
-
Sterility
- Sterile filtered
-
Immunogen
- Anti-Troponin (cardiac) Antibody was produced in rabbits by repeated immunizations with a fusion protein of complete mouse cardiac troponin 1.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
ELISA_Dilution: 1:20,000
Western_Blot_Dilution: 1:2000 (or higher in cardiac muscle)
-
Comment
-
Anti-Troponin (cardiac) Antibody has been tested in Western Blots and is specific for the ~25 kDa cardiac troponin I protein. Specific conditions for reactivity should be optimized by the end user.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Buffer: None
Stabilizer: None
Preservative: None -
Preservative
- Without preservative
-
Storage
- -20 °C
-
Storage Comment
- Store vial at -20° C prior to opening in undiluted aliquots. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature.
-
Expiry Date
- 12 months
-
-
- TNNI3 (Cardiac Troponin I (TNNI3))
-
Alternative Name
- Troponin I (cardiac)
-
Background
-
Synonyms: Troponin I cardiac muscle, Cardiac troponin I
Background: Troponin I (cTnI) is 1 of 3 subunits, along with troponin C (TnC) and troponin T (TnT) of troponin complex found in cardiac muscle. cTnI binds to actin in thin myofilaments to hold the troponin-tropomyosin complex in place. Phosphorylation of cardiac isoform of TnI at serines 22,23 in the unique amino-terminal end molecule decreases the calcium sensitivity of the sarcomere, promotes calcium dissociation from troponin C and by extension enhances rates of cross-bridge cycling and diastolic relaxation. In addition, studies using reconstituted fibers and mutational analysis have shown that PKC phosphorylation of TnI (largely at Ser43) inhibits the actin-cross bridge reaction and reduces the Ca++ dependent actomyosin ATPase rate as well as the calcium sensitivity of force generation. Phosphorylation at Thr144 (mediated by several PKC isoforms) reduces maximal tension development and cross-bridge cycling rates. Importantly, changes in the phosphorylation at each of these sites have been shown to be stage-specific with regard to cardiac disease progression. Troponin I Antibody is ideal for researchers interested in cancer research.
Gene Name: TNNI3
-
Gene ID
- 21954
-
NCBI Accession
- NP_033432
-
UniProt
- P48787
Target
-